Data for: "Manufacturing considerations for the development of lipid nanoparticles using microfluidics"



In the recent of years, the use of lipid nanoparticles (LNPs) for RNA delivery has gained considerable attention, with a large number in the clinical pipeline as vaccine candidates or to treat a wide range of diseases. Microfluidics offers considerable advantages for their manufacture due to its scalability, reproducibility and fast preparation. Thus, in this study, we have evaluated operating and formulation parameters to be considered when developing LNPs. Among them, the flow rate ratio (FRR) and total flow rate (TFR) have been shown to significantly influence the physicochemical characteristics of the produced particles. In particular, increasing the TFR or increasing the FRR decreased particle size. The cationic lipid choice (DOTAP, DDAB or MC3), buffer choice (citrate buffer pH 6 or TRIS pH 7.4) and type of nucleic acid payload (PolyA, ssDNA or mRNA) have also been shown to have an impact on the characteristics of these LNPs. LNPs were shown to have high (> 90%) loading in all cases, and were below 100 nm with low polydispersity index (≤ 0.25). The results within this paper could be used as a guide for the development and scalable manufacture of LNP systems using microfluidics.
Date made available26 Nov 2020
PublisherUniversity of Strathclyde
Date of data production8 Jun 2020 - 30 Sept 2020

Cite this